Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,492 | -761 | -7,172 | -6,607 | -3,197 |
| Depreciation Amortization | N/A | N/A | 14 | 10 | 7 |
| Accounts receivable | 4 | -15 | 237 | 221 | 239 |
| Other Working Capital | -269 | -537 | 2,627 | 1,802 | 1,879 |
| Other Operating Activity | 392 | 243 | 3,143 | 3,549 | 507 |
| Operating Cash Flow | $-1,365 | $-1,070 | $-1,151 | $-1,024 | $-566 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,404 | N/A | 1,022 | 926 | 446 |
| Other Financing Activity | 0 | 1,258 | 0 | 0 | 0 |
| Financing Cash Flow | $1,404 | $1,258 | $1,022 | $926 | $446 |
| Exchange Rate Effect | 0 | 0 | 2 | -1 | -3 |
| Beginning Cash Position | 6 | 7 | 133 | 130 | 135 |
| End Cash Position | 46 | 195 | 6 | 31 | 11 |
| Net Cash Flow | $40 | $189 | $-126 | $-99 | $-124 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,365 | -1,070 | -1,151 | -1,024 | -566 |
| Free Cash Flow | -1,365 | -1,070 | -1,151 | -1,024 | -566 |